Epic seeks to dismiss Particle Health’s antitrust suit
The two companies have been feuding since March.
Related Articles
How Health Organizations Can Collaborate to Keep Up With AI
This Medical News article is an interview with Michael Pencina, PhD, Duke Health’s chief data scientist, about the need for health systems to collaborate to…
“I Had No Words”: The Patient Gifts Doctors Never Forget
These doctors were surprised and moved by very personal gifts given to them by grateful patients. Enjoy some good vibes this holiday season.
Brain Research Finds Differences in Changes Based on Sex, Race
Two new studies that delve into Alzheimer’s-related brain changes show the need for a fuller understanding of how race and sex influence the condition.
What is brain rot? How modern life is turning our minds to mush
We all need to get our digital consumption in balance – or face the mental consequences
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity
Tirzepatide’s approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.
FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD
The FDA’s decision not to approve sotagliflozin as an adjunct in T1D and CKD comes less than 2 months after a negative advisory committee meeting…
The G2 on The UiPath Platform™
Filter 6663 reviews by the users’ company size, role or industry to find out how The UiPath Platform™ works for a business like yours.
California Declares an Emergency Over Bird Flu
Officials have discovered the virus in 645 herds of dairy cattle, more than in any other state so far.
Medical supply firm Medline confidentially files for potential blockbuster IPO in 2025
Medical equipment and supply manufacturer Medline Industries confidentially submitted plans for a proposed initial public offering, potentially setting the stage for a blockbuster public debut…
